Vasee Moorthy

8.0k total citations
65 papers, 2.9k citations indexed

About

Vasee Moorthy is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Vasee Moorthy has authored 65 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Public Health, Environmental and Occupational Health, 21 papers in Infectious Diseases and 17 papers in Epidemiology. Recurrent topics in Vasee Moorthy's work include Malaria Research and Control (25 papers), Mosquito-borne diseases and control (21 papers) and Viral Infections and Outbreaks Research (13 papers). Vasee Moorthy is often cited by papers focused on Malaria Research and Control (25 papers), Mosquito-borne diseases and control (21 papers) and Viral Infections and Outbreaks Research (13 papers). Vasee Moorthy collaborates with scholars based in Switzerland, United Kingdom and United States. Vasee Moorthy's co-authors include Adrian V. S. Hill, Birgitte Giersing, Kayvon Modjarrad, Peter G. Smith, David C. Kaslow, Robert W. Sauerwein, Meta Roestenberg, Graham V. Brown, Michael F. Good and Blaise Genton and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Vasee Moorthy

64 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasee Moorthy Switzerland 32 1.3k 854 799 646 582 65 2.9k
Johan Vekemans United Kingdom 35 1.5k 1.1× 948 1.1× 1.2k 1.5× 479 0.7× 1.3k 2.3× 69 3.5k
Nadia Tornieporth United States 27 2.0k 1.5× 1.6k 1.8× 1.3k 1.6× 799 1.2× 812 1.4× 46 4.2k
Joseph Torresi Australia 43 1.9k 1.4× 1.6k 1.9× 2.2k 2.8× 447 0.7× 396 0.7× 145 5.4k
Ali A. Sultan Qatar 26 1.5k 1.1× 525 0.6× 554 0.7× 615 1.0× 777 1.3× 98 3.0k
Birgitte Giersing Switzerland 25 502 0.4× 700 0.8× 636 0.8× 345 0.5× 304 0.5× 77 2.0k
W. Ripley Ballou United States 32 2.1k 1.6× 662 0.8× 749 0.9× 1.1k 1.8× 1.1k 1.8× 48 3.5k
Kalifa Bojang Gambia 37 3.3k 2.5× 605 0.7× 529 0.7× 815 1.3× 914 1.6× 83 4.6k
Martin Friede Switzerland 26 386 0.3× 653 0.8× 848 1.1× 656 1.0× 954 1.6× 52 2.6k
Pathom Sawanpanyalert Thailand 33 876 0.7× 2.1k 2.5× 1.8k 2.3× 442 0.7× 478 0.8× 165 4.0k
Peter Siba Papua New Guinea 37 2.5k 1.9× 578 0.7× 627 0.8× 356 0.6× 574 1.0× 146 4.1k

Countries citing papers authored by Vasee Moorthy

Since Specialization
Citations

This map shows the geographic impact of Vasee Moorthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasee Moorthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasee Moorthy more than expected).

Fields of papers citing papers by Vasee Moorthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasee Moorthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasee Moorthy. The network helps show where Vasee Moorthy may publish in the future.

Co-authorship network of co-authors of Vasee Moorthy

This figure shows the co-authorship network connecting the top 25 collaborators of Vasee Moorthy. A scholar is included among the top collaborators of Vasee Moorthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasee Moorthy. Vasee Moorthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, An‐Wen, Ghassan Karam, Lisa Askie, et al.. (2025). Reporting summary results in clinical trial registries: updated guidance from WHO. The Lancet Global Health. 13(4). e759–e768. 5 indexed citations
2.
Cavaleri, Marco, Adam Hacker, Murray Lumpkin, et al.. (2025). A roadmap for fostering timely regulatory and ethics approvals of international clinical trials in support of global health research systems. The Lancet Global Health. 13(4). e769–e777. 6 indexed citations
3.
Cesari, Matteo, Marco Canevelli, Wei Zhang, et al.. (2025). Enhancing the methodology of clinical trials in older people: A scoping review with global perspective. The journal of nutrition health & aging. 29(6). 100582–100582. 1 indexed citations
4.
Mateen, Bilal A., Vasee Moorthy, Alain Labrique, & Jeremy Farrar. (2025). Artificial intelligence and clinical trials: a framework for effective adoption. The Lancet Digital Health. 7(8). 100898–100898. 1 indexed citations
5.
Moorthy, Vasee & Jeremy Farrar. (2025). Identifying key randomised clinical trials that could transform clinical care and public health. The Lancet. 405(10479). 607–608.
6.
Moorthy, Vasee, Ibrahim Abubakar, Firdausi Qadri, et al.. (2023). The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum. The Lancet. 403(10422). 124–126. 22 indexed citations
7.
Vekemans, Johan, Vasee Moorthy, Martin Friede, et al.. (2018). Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 37(50). 7391–7393. 46 indexed citations
9.
Giersing, Birgitte, Sana Dastgheyb, Kayvon Modjarrad, & Vasee Moorthy. (2016). Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine. 34(26). 2962–2966. 116 indexed citations
10.
Kobayashi, Miwako, Stephanie J. Schrag, Mark R. Alderson, et al.. (2016). WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016. Vaccine. 37(50). 7307–7314. 74 indexed citations
11.
Moorthy, Vasee, Raymond Hutubessy, Robert D. Newman, & Joachim Hombach. (2012). Decision-making on malaria vaccine introduction: the role of cost-effectiveness analysis. Bulletin of the World Health Organization. 90(11). 864–866. 12 indexed citations
12.
Vannice, Kirsten, Graham V. Brown, Bartholomew D. Akanmori, & Vasee Moorthy. (2012). MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines. Malaria Journal. 11(1). 372–372. 20 indexed citations
13.
Menéndez, Clara, Vasee Moorthy, Zarifah Reed, et al.. (2011). Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report. Expert Review of Vaccines. 10(9). 1271–1280. 5 indexed citations
14.
Pinder, M, Vasee Moorthy, Bartholomew D. Akanmori, Blaise Genton, & G V Brown. (2010). MALVAC 2009: Progress and Challenges in Development of Whole Organism Malaria Vaccines for Endemic Countries, 3–4 June 2009, Dakar, Senegal. Vaccine. 28(30). 4695–4702. 9 indexed citations
15.
Moorthy, Vasee, Peter G. Smith, & Marie-Paule Kiény. (2009). A vaccine against malaria: a substantial step forward. The Lancet. 373(9673). 1411–1412. 4 indexed citations
16.
Moorthy, Vasee, C. L. Diggs, Michael F. Good, et al.. (2009). Report of a Consultation on the Optimization of Clinical Challenge Trials for Evaluation of Candidate Blood Stage Malaria Vaccines, 18–19 March 2009, Bethesda, MD, USA. Vaccine. 27(42). 5719–5725. 36 indexed citations
17.
Gilbert, Sarah C., Vasee Moorthy, Laura Andrews, et al.. (2005). Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine. 24(21). 4554–4561. 88 indexed citations
18.
Moorthy, Vasee, Michael F. Good, & Adrian V. S. Hill. (2004). Malaria vaccine developments. The Lancet. 363(9403). 150–156. 150 indexed citations
19.
Moorthy, Vasee, Egeruan B. Imoukhuede, Paul Milligan, et al.. (2004). A Randomised, Double-Blind, Controlled Vaccine Efficacy Trial of DNA/MVA ME-TRAP Against Malaria Infection in Gambian Adults. PLoS Medicine. 1(2). e33–e33. 128 indexed citations
20.
Moorthy, Vasee, Egeruan B. Imoukhuede, Sheila M. Keating, et al.. (2004). Phase 1 Evaluation of 3 Highly Immunogenic Prime‐Boost Regimens, Including a 12‐Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men. The Journal of Infectious Diseases. 189(12). 2213–2219. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026